Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

PFE

Pfizer Inc

Feb 04 • 04:00PM ET

25.87

Dollar change -0.33
Percentage change -1.26	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK JNJ ABBV BMY LLY GILD AMGN BIIB REGN VRTX

| Held by: VTI VOO SCHD SPY IVV VTV XLV VYM VHT MOAT

Scroll to Statements

Index	S&P 500	P/E	34.78	EPS (ttm)	0.74	Insider Own	0.04%	Shs Outstand	5.67B	Perf Week	-3.29%
Market Cap	146.61B	Forward P/E	8.54	EPS next Y	3.03	Insider Trans	-0.18%	Shs Float	5.66B	Perf Month	-2.78%
Income	4.27B	PEG	-	EPS next Q	0.69	Inst Own	67.64%	Short Float	1.62%	Perf Quarter	-8.59%
Sales	60.11B	P/S	2.44	EPS this Y	-6.34%	Inst Trans	-0.29%	Short Ratio	2.11	Perf Half Y	-14.99%
Book/sh	16.29	P/B	1.59	EPS next Y	4.01%	ROA	1.97%	Short Interest	91.78M	Perf Year	-5.20%
Cash/sh	1.76	P/C	14.73	EPS next 5Y	-1.06%	ROE	4.52%	52W Range	24.48 - 31.54	Perf YTD	-2.49%
Dividend Est.	1.70 (6.57%)	P/FCF	17.82	EPS past 5Y	-13.25%	ROI	2.84%	52W High	-17.98%	Beta	0.58
Dividend TTM	1.69 (6.53%)	Quick Ratio	0.73	Sales past 5Y	19.51%	Gross Margin	58.50%	52W Low	5.68%	ATR (14)	0.58
Dividend Ex-Date	Jan 24, 2025	Current Ratio	1.00	EPS Y/Y TTM	-59.54%	Oper. Margin	16.32%	RSI (14)	42.98	Volatility	2.42% 2.07%
Employees	88000	Debt/Eq	0.73	Sales Y/Y TTM	-12.29%	Profit Margin	7.11%	Recom	2.23	Target Price	30.80
Option/Short	Yes / Yes	LT Debt/Eq	0.63	EPS Q/Q	284.91%	Payout	439.41%	Rel Volume	1.57	Prev Close	26.20
Sales Surprise	2.38%	EPS Surprise	33.59%	Sales Q/Q	33.78%	Earnings	Feb 04 BMO	Avg Volume	43.49M	Price	25.87
SMA20	-2.51%	SMA50	-1.17%	SMA200	-7.22%	Trades		Volume	68,299,001	Change	-1.26%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60

Show Previous Ratings

Today 02:12AM	Pfizer Inc (PFE) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements (GuruFocus.com)
02:04AM	Q4 2024 Pfizer Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-04-25 07:02PM	Italian charity seeks EMA approval for rescued gene therapy (Pharmaceutical Technology)
04:13PM	RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box. (Investor's Business Daily)
04:12PM	Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable? (Investor's Business Daily)
03:32PM	Loading…
03:32PM	RFK Jr. 'tempered' his stance on vaccines in private discussions, Pfizer CEO says (Yahoo Finance)
02:34PM	RFK Jr. Clears Committee Vote, Is On Track to Become Health Secretary (The Wall Street Journal)
02:21PM	Analyst Report: Pfizer Inc. (Morningstar Research)
02:10PM	Pfizer Falls on RFKs Progress Towards Confirmation Despite Good Earnings. Its CEO is Unbothered. (Barrons.com)
02:00PM	Pfizer (PFE) Q4 2024 Earnings Call Transcript (Motley Fool)
02:00PM	Pfizer's CEO is 'cautiously optimistic' about RFK Jr. as Trump's health secretary (Quartz)
01:48PM	Drug Stocks Stumble as RFK Jr.s HHS Nomination Moves Forward to a Senate Vote (Barrons.com)
12:40PM	Estée Lauder job cuts, Merck guidance, PepsiCo: Market Minute (Yahoo Finance Video)
12:36PM	Pfizer, Merck Q4 earnings: A break down of the pharma stocks (Yahoo Finance Video)
11:55AM	Health, pharma stocks fall as RFK Jr. clears crucial vote (Yahoo Finance Video)
10:47AM	Loading…
10:47AM	Pfizer Shares Fall Despite EPS Soaring 530% in Q4 (GuruFocus.com)
09:56AM	Pfizer Rises on Q4 Earnings Beat, 2025 Outlook Reaffirmed (GuruFocus.com)
09:50AM	Pfizer beats Q4, FY '24 earnings estimates, stock flat in early trading (Yahoo Finance)
09:30AM	Compared to Estimates, Pfizer (PFE) Q4 Earnings: A Look at Key Metrics (Zacks)
09:26AM	Mizuho's Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks (CNBC TV)
09:16AM	Pfizer Q4 Earnings: Revenue And EPS Beat, Seagen And COVID-19 Products Show Strength, Issues Strong FY25 Outlook (Benzinga)
09:12AM	Pfizer Stock Rises on Fourth-Quarter Earnings Beat and Reaffirmed Guidance (Barrons.com)
08:52AM	Pfizer Edges Higher As Covid Sales Decline, But Still Beat Expectations (Investor's Business Daily)
08:52AM	Pfizer beats Q4, FY '24 earnings estimates, stock flat in premarket trading (Yahoo Finance)
08:52AM	Pfizer beats Q4, FY '24 earnings estimates, stock down slightly in premarket trading (Yahoo Finance)
08:22AM	Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4 (StockStory)
08:21AM	Merck beats estimates on Q4 earnings, stock slides on tepid 2025 guidance (Yahoo Finance)
08:21AM	Merck beats estimates on fourth-quarter on earningsbut stock slides pre-market on tepid 2025 guidance (Yahoo Finance)
08:00AM	Pfizer (PFE) Beats Q4 Earnings and Revenue Estimates (Zacks)
07:06AM	Pfizer: Q4 Earnings Snapshot (Associated Press Finance)
06:53AM	Loading…
06:53AM	Pfizer beats profit estimates on cost cuts, COVID vaccine sales (Reuters)
06:45AM	Pfizer Reports Strong Full-Year 2024 Results And Reaffirms 2025 Guidance (Business Wire)
05:06AM	2 Ultra-High-Yield Dividend Stocks That Are No-Brainer Buys in February (Motley Fool)
Feb-03-25 07:00PM	Alphabet earnings, Fed commentary, JOLTS data: What to Watch (Yahoo Finance Video)
05:03PM	Pfizer Is About to Report Its Earnings. The Stock Has Been Floundering. (Barrons.com)
02:08PM	Pfizer's Groundbreaking Cancer Drug Hits a Major Milestone--What It Means for Investors (GuruFocus.com)
01:17PM	Jim Cramer on Pfizer Inc. (PFE): The Stock Could Soar, Very Little Downside At These Low Levels (Insider Monkey)
01:08PM	Pfizers colon cancer combo approval further supported by Phase III win (Clinical Trials Arena)
08:03AM	Is Pfizer Inc. (PFE) the Best Cancer Stock to Buy According to Hedge Funds? (Insider Monkey)
08:00AM	If You Invested $10,000 In Pfizer Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
06:45AM	Pfizers BRAFTOVI Combination Regimen Significantly Improved Progression-Free Survival and Overall Survival in Phase 3 BREAKWATER Trial (Business Wire)
06:45AM	Pfizer drug acquired in $11B buyout confirms benefit in colon cancer (BioPharma Dive)
06:03AM	Smaller US winter COVID wave adds pressure to Pfizer turnaround (Reuters)
Feb-02-25 02:19PM	Heres Why Pfizer Inc. (PFE) Is Among the Best Dividend Stocks Under $30 (Insider Monkey)
05:00AM	Big Pharma has a big Super Bowl dilemma (Quartz)
Feb-01-25 04:00AM	Major players in the anti-DEI movement: Heres whos attacking Goldman Sachs, Pfizer, IBM, and other Fortune 500 companies (Fortune)
03:31AM	Why Pfizer Inc. (PFE) Is Among the Best Long Term Low Risk Stocks to Buy Now (Insider Monkey)
Jan-31-25 05:50PM	Altria Is the New Dividend Leader in the S&P 500. Shares Yield Nearly 8%. (Barrons.com)
05:24PM	Pfizer resolves conservative challenge to diversity fellowship program (Reuters)
05:02PM	Investing Action Plan: A Big Week For Biotechs, Pharma And Econ, Plus Amazon And Alphabet (Investor's Business Daily)
10:50AM	AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing (Yahoo Finance Video)
09:00AM	Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know (Zacks)
Jan-30-25 03:02PM	Jim Cramer on Pfizer Inc. (PFE): Its Too Low To Sell (Insider Monkey)
09:50AM	Pfizer (PFE) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
09:15AM	Exploring Analyst Estimates for Pfizer (PFE) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Jan-29-25 08:00AM	The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings (Investor's Business Daily)
Jan-28-25 11:36PM	Is Pfizer Inc. (PFE) the Safe Stock to Buy for the Long Term in 2025? (Insider Monkey)
05:45PM	Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
03:00PM	Drugmakers Show Restraint on Price Increases in New Trump Era (The Wall Street Journal)
02:34PM	Pfizer Inc. (PFE): Is This Healthcare Stock A Good Buy? (Insider Monkey)
06:45AM	Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium (Business Wire)
06:15AM	I Own 4 High-Yield Dividend Stocks. Here's Why I Own Each One. (Motley Fool)
Jan-27-25 04:21PM	Pfizer Jumps After Avoiding Proxy Fight With Activist Investor Starboard For Now (Investor's Business Daily)
03:58PM	Pfizer gains after activist investor forgoes board nominations (Yahoo Finance Video)
02:23PM	Pfizer's Conditionally Approved Braftovi Combo Therapy Regime Shows Improved Response In Colorectal Cancer Patients (Benzinga)
11:22AM	Pfizer settles Biohaven kickback claims case for $59.7m (Pharmaceutical Technology)
08:33AM	Four Years After Covid-19 Success, mRNA Vaccines Arent Ready for Bird Flu (Barrons.com)
07:08AM	Pfizer reports positive outcomes from trial of mCRC combination therapy (Clinical Trials Arena)
Jan-26-25 09:30AM	Have $500? 2 High-Yield Dividend Stocks to Buy Right Now (Motley Fool)
Jan-25-25 03:00PM	Pfizer's BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer (Business Wire)
08:11AM	Pfizer to pay nearly $60M over kickbacks for migraine drug once promoted by Lady Gaga (Fox Business)
05:46AM	Got $100? This Top Dividend ETF Is a No-Brainer Buy Right Now. (Motley Fool)
Jan-24-25 05:55PM	Pfizer to pay $59.7 million over kickbacks for migraine drug (Reuters)
05:48PM	Pfizer to Pay $60 Million in Kickback, False Claims Settlement (The Wall Street Journal)
04:14PM	Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots (Investor's Business Daily)
03:00AM	Gene therapies have been uneven for DMD but these companies hope to turn the tide (Pharma Voice)
Jan-23-25 09:40AM	Here's Why Pfizer (PFE) is a Strong Value Stock (Zacks)
09:39AM	Is Pfizer Stock A Buy After Shares Rally On A Recent Covid Spike? (Investor's Business Daily)
08:14AM	Why Is Prem Watsa Bullish On Pfizer Inc. (PFE) Now? (Insider Monkey)
07:30AM	Can This Beaten-Down Stock Bounce Back in 2025? (Motley Fool)
04:15AM	My Top 5 Stocks to Buy in Early 2025 (Motley Fool)
02:00AM	BridgeBios Neil Kumar on an underdog drug launch and wooing deal-hungry investors (BioPharma Dive)
Jan-22-25 01:44PM	Is Pfizer Inc. (PFE) the Best Stock to Invest In For Steady Dividends? (Insider Monkey)
06:16AM	Is Pfizer Stock a Buy? (Motley Fool)
Jan-21-25 05:45PM	Why Pfizer (PFE) Outpaced the Stock Market Today (Zacks)
10:28AM	Why Is Pfizer Inc. (PFE) Among the Best High-Yield Dividend Stocks to Invest In? (Insider Monkey)
07:10AM	Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever (Motley Fool)
Jan-20-25 11:10AM	Is Pfizer Inc. (PFE) the Undervalued Defensive Stock for 2025? (Insider Monkey)
10:21AM	Pfizer CEO: Americans can expect radical change from this upcoming Trump administration (CNBC TV)
09:00AM	Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock (Zacks)
07:00AM	Beaten Down Under Biden, Big Pharma Hopes for New Chapter Under Trump (The Wall Street Journal)
04:52AM	Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,000 in Passive Income in 2025 (Motley Fool)
Jan-19-25 05:51AM	The Smartest Dividend Stocks to Buy With $100 Right Now (Motley Fool)
Jan-18-25 05:05PM	Why Pfizer (PFE) Is One of the Best Cheap Stocks to Buy for 2025? (Insider Monkey)
08:20AM	Ozempic, Xtandi among next 15 drugs selected for U.S. price talks (TipRanks)
05:42AM	Why I Just Bought These 3 Ultra-High-Yield Dividend Stocks (Motley Fool)
Jan-17-25 04:13PM	Medicare to negotiate prices on 15 drugs, including Ozempic (Yahoo Finance Video)
01:55PM	Here's How Donald Trump Could Shake Up Health Care And Biotech Stocks (Investor's Business Daily)
12:15PM	Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations (Benzinga)
11:10AM	Ozempic Among the Next Drugs Up for Medicare Price Negotiations (The Wall Street Journal)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM
McDermott Michael	Executive Vice President	Feb 23 '24	Option Exercise	27.34	12,412	339,344	95,408	Feb 27 01:47 PM
SUSMAN SALLY	Executive Vice President	Feb 23 '24	Option Exercise	27.34	63,837	1,745,304	218,148	Feb 27 01:46 PM
SAHNI PAYAL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	11,527	315,148	34,604	Feb 27 01:46 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 23 '24	Option Exercise	27.34	95,755	2,617,942	230,920	Feb 27 01:46 PM
JOHNSON RADY A	Executive Vice President	Feb 23 '24	Option Exercise	27.34	29,436	804,780	123,073	Feb 27 01:46 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 23 '24	Option Exercise	27.34	9,752	266,620	19,228	Feb 27 01:46 PM
BOURLA ALBERT	Chairman & CEO	Feb 23 '24	Option Exercise	27.34	127,674	3,490,607	439,748	Feb 27 01:46 PM
BOSHOFF CHRISTOFFEL	Executive Vice President	Feb 23 '24	Option Exercise	27.34	9,752	266,620	148,703	Feb 27 01:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience